Janina Czartolomna
Internal Medicine · Denver, CONPI 1720071996
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,473 and has fallen 51.8% since, to $710 in 2022. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$632
- AbbVie$504
- Novo Nordisk$444
- Lilly USA, LLC$223
- Merck$210
- Boehringer Ingelheim$197
- plus $1K from 32 others
What the payments were for
- Food & beverage$3,700100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $632 |
| AbbVie(2 entities) | 32 | $504 |
| Novo Nordisk | 24 | $444 |
| Lilly USA, LLC | 18 | $223 |
| Merck | 15 | $210 |
| Boehringer Ingelheim | 10 | $197 |
| Amarin Pharma, Inc. | 9 | $172 |
| Pfizer | 10 | $145 |
| GSK | 8 | $113 |
| Bayer | 5 | $107 |
| Amgen | 5 | $104 |
| Johnson & Johnson | 4 | $66 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $65 |
| Abbott | 3 | $63 |
| Astellas Pharma US Inc | 4 | $63 |
| Genentech USA, Inc. | 3 | $62 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Eisai Inc. | 3 | $48 |
| Medtronic | 1 | $40 |
| Grifols USA, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Alfasigma USA, Inc. | 2 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 2 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Organon | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$111
How this compares
$3,700 in reported general payments places this provider in the 90th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Denver
- Kenneth OleszekDenver$60K
- Robert KeithDenver$49K
- Elena AnisimovaDenver$36K
- Chase BlackfordDenver$30K
- Matthew KoslowDenver$21K
- Katherine TsaiDenver$15K
- Saurabh MangalikDenver$14K
- David MellmanDenver$12K
- Cara DawsonDenver$11K
- Jason HenryDenver$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.